Plain-English translation of NCT06516133 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing whether a newer type of radiation therapy called online adaptive radiotherapy can work as well as — or better than — standard radiation therapy for nasopharyngeal carcinoma (throat cancer). The new approach uses artificial intelligence to adjust your treatment plan each day based on small changes in your body, which may reduce side effects while keeping the cancer treatment just as effective.
Standard radiation therapy uses the same treatment plan for every session, but your body changes slightly from day to day. This trial wants to see whether adjusting the plan daily can spare healthy tissues from radiation damage and reduce side effects, while still fighting the cancer just as well.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive either standard radiation therapy or the new adaptive radiation therapy, both possibly combined with . With adaptive therapy, your treatment plan will be adjusted each day based on images taken before each session, allowing doctors to account for changes in your body. You will attend regular visits for imaging, blood tests, and follow-up care to monitor how well the treatment is working and any side effects you experience.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China